Dexcom (DXCM) Other Non-Current Assets (2016 - 2026)
Dexcom has reported Other Non-Current Assets over the past 17 years, most recently at $285.9 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 69.67% to $285.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $285.9 million through Mar 2026, up 69.67% year-over-year, with the annual reading at $278.7 million for FY2025, 61.1% up from the prior year.
- Other Non-Current Assets was $285.9 million for Q1 2026 at Dexcom, up from $278.7 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $285.9 million in Q1 2026 and troughed at $22.8 million in Q1 2022.
- The 5-year median for Other Non-Current Assets is $77.7 million (2024), against an average of $118.1 million.
- The largest YoY upside for Other Non-Current Assets was 348.57% in 2022 against a maximum downside of 6.44% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $47.1 million in 2022, then soared by 59.24% to $75.0 million in 2023, then surged by 130.67% to $173.0 million in 2024, then skyrocketed by 61.1% to $278.7 million in 2025, then grew by 2.58% to $285.9 million in 2026.
- Per Business Quant, the three most recent readings for DXCM's Other Non-Current Assets are $285.9 million (Q1 2026), $278.7 million (Q4 2025), and $276.5 million (Q3 2025).